• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

NTU scientists use dead bacteria to kill colorectal cancer

Bioengineer.org by Bioengineer.org
January 28, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.

Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteria in its dead form, and its secretions, to destroy colon tumours cells effectively.

Colorectal cancer is the number one cancer in Singapore and the foremost cancer amongst males as stated by Singapore's Health Promotion Board. It is also the third most common cancer in the world, with about 1.4 million new cases annually, estimated by the World Cancer Research Fund International.

Led by NTU Professor Teoh Swee Hin, this study was published last month in the peer-reviewed journal, Scientific Reports, under the prestigious Nature publishing group.

Traditional cancer treatments like chemotherapy and radiotherapy do not work well in the colon due to reduced blood flow and the lack of oxygen and nutrient flow in the tumour environment. This is because such therapies rely on oxygen molecules to damage the DNA of cancer cells and blood flow to transport therapeutic drugs to the tumour.

In contrast, the NTU team showed that dead C. sporogenes bacteria can kill tumour cells in an oxygen-starved tumour microenvironment.

Prof Teoh, who is Chair of NTU's School of Chemical and Biomedical Engineering said this discovery opens new doors for the treatment of colon cancer as bacteria therapy is recently gaining interest as an alternative to traditional treatments.

"We found that even when the C. sporogenes bacteria is dead, its natural toxicity continues to kill cancer cells, unlike the conventional chemotherapy drugs which need oxygen to work," explained Prof Teoh.

"While other research groups have experimented with bacteria therapy to destroy cancer cells, the biggest problem is that live bacteria will grow and proliferate, posing a high risk of infection and increased toxicity to patients.

"In the NTU study, as the bacteria were already killed by heat, there was no risk of the bacteria multiplying and causing more harm than the desired dose meant to kill colorectal cancer cells."

The NTU team conducted experiments in 3D cell culture which were artificially-created environments, resembling the inside of a human body, unlike most lab experiments which are done on a flat surface in a petri-dish.

In a 72-hour experiment, the inactive bacteria were able to reduce the growth of colon tumour cells by 74 per cent. In addition, the team tested the secretions harvested from a live bacteria culture and these secretions reduced growth of colon tumour cells by as much as 83 per cent.

Professor James Best, Dean of NTU's Lee Kong Chian School of Medicine, said: "This is a significant discovery that potentially opens a new avenue to tackle this very common cancer, which is difficult to treat after it has spread. While it is early days, this exciting research finding provides hope of a new treatment option for millions of people affected by bowel cancer each year."

Moving forward, the NTU team is looking to study the specific components of the bacteria which help to kill tumour cells and to develop them into usable therapy such as cancer drugs.

###

About Nanyang Technological University

A research-intensive public university, Nanyang Technological University, Singapore (NTU Singapore) has 33,500 undergraduate and postgraduate students in the colleges of Engineering, Business, Science, Humanities, Arts, & Social Sciences, and its Interdisciplinary Graduate School. It has a new medical school, the Lee Kong Chian School of Medicine, set up jointly with Imperial College London.

NTU is also home to world-class autonomous institutes – the National Institute of Education, S Rajaratnam School of International Studies, Earth Observatory of Singapore, and Singapore Centre on Environmental Life Sciences Engineering – and various leading research centres such as the Nanyang Environment & Water Research Institute (NEWRI), Energy Research Institute @ NTU ([email protected]) and the Institute on Asian Consumer Insight (ACI).

A fast-growing university with an international outlook, NTU is putting its global stamp on Five Peaks of Excellence: Sustainable Earth, Future Healthcare, New Media, New Silk Road, and Innovation Asia.

The University's main campus has been named one of the Top 15 Most Beautiful in the World. NTU also has a campus in Novena, Singapore's medical district.

For more information, visit http://www.ntu.edu.sg

Share12Tweet7Share2ShareShareShare1

Related Posts

Breast Cancer Progression: Evolving Microenvironments and Patterns

September 28, 2025

Radiopharmaceutical Combined with Stereotactic Radiation Slows Progression of Oligometastatic Prostate Cancer

September 28, 2025

Low-Dose Radiation Therapy Provides Significant Relief for Painful Knee Osteoarthritis

September 28, 2025

ASTRO: Innovative Therapy Slows Progression of Recurrent Prostate Cancer

September 28, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    85 shares
    Share 34 Tweet 21
  • Physicists Develop Visible Time Crystal for the First Time

    72 shares
    Share 29 Tweet 18
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    56 shares
    Share 22 Tweet 14
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Breast Cancer Progression: Evolving Microenvironments and Patterns

Radiopharmaceutical Combined with Stereotactic Radiation Slows Progression of Oligometastatic Prostate Cancer

Low-Dose Radiation Therapy Provides Significant Relief for Painful Knee Osteoarthritis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.